NM_000268.4(NF2):c.12C>T (p.Ala4=) AND Neurofibromatosis, type 2

Germline classification:: Benign/Likely benign (3 submissions)
Last evaluated:: Jan 24, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000231489.19

Allele description [Variation Report for NM_000268.4(NF2):c.12C>T (p.Ala4=)]

NM_000268.4(NF2):c.12C>T (p.Ala4=)

Gene:

NF2:NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

22q12.2

Genomic location:

Preferred name:

NM_000268.4(NF2):c.12C>T (p.Ala4=)

HGVS:

NC_000022.11:g.29604010C>T
NG_009057.1:g.5455C>T
NM_000268.4:c.12C>TMANE SELECT
NM_016418.5:c.12C>T
NM_181825.3:c.12C>T
NM_181828.3:c.12C>T
NM_181829.3:c.12C>T
NM_181830.3:c.12C>T
NM_181831.3:c.12C>T
NM_181832.3:c.12C>T
NM_181833.3:c.12C>T
NP_000259.1:p.Ala4=
NP_000259.1:p.Ala4=
NP_057502.2:p.Ala4=
NP_861546.1:p.Ala4=
NP_861966.1:p.Ala4=
NP_861967.1:p.Ala4=
NP_861968.1:p.Ala4=
NP_861969.1:p.Ala4=
NP_861970.1:p.Ala4=
NP_861971.1:p.Ala4=
LRG_511t1:c.12C>T
LRG_511t2:c.12C>T
LRG_511:g.5455C>T
LRG_511p1:p.Ala4=
LRG_511p2:p.Ala4=
NC_000022.10:g.29999999C>T
NM_000268.3:c.12C>T
NM_000268.4:c.12C>T
NM_181832.2:c.12C>T
NR_156186.2:n.378C>T

Links:

dbSNP: rs144477078

NCBI 1000 Genomes Browser:

rs144477078

Molecular consequence:

NR_156186.2:n.378C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NM_000268.4:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_016418.5:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_181825.3:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_181828.3:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_181829.3:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_181830.3:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_181831.3:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_181832.3:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]
NM_181833.3:c.12C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:: Neurofibromatosis, type 2 (SWNV)
Synonyms:: NF 2; Neurofibromatosis central type; Acoustic schwannomas bilateral; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0007039; MedGen: C0027832; Orphanet: 637; OMIM: 101000

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000284542	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Benign (Jan 24, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV000437746	Illumina Laboratory Services, Illumina	criteria provided, single submitter (ICSL Variant Classification Criteria 13 December 2019)	Likely benign (Oct 25, 2018)	germline	clinical testing	Citation Link,
SCV002044919	Genome-Nilou Lab	criteria provided, single submitter (ACMG Guidelines, 2015)	Benign (Nov 7, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000284542

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Benign
(Jan 24, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000437746

Illumina Laboratory Services, Illumina

criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)

Likely benign
(Oct 25, 2018)

germline

clinical testing

Citation Link,

SCV002044919

Genome-Nilou Lab

criteria provided, single submitter

(ACMG Guidelines, 2015)

Benign
(Nov 7, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	no	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000284542.10

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Illumina Laboratory Services, Illumina, SCV000437746.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Genome-Nilou Lab, SCV002044919.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	no	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine